This webinar from the UK Bioindustry Association (BIA) is part of a series of BIA Brexit Briefings that provide updates for UK and International audiences answering 'What does Brexit mean for Biotechnology in the UK and beyond?
Following the end of the Brexit transition period of 1 January 2021, new customs and regulatory requirements have come into force with further requirements due in the coming years.
This webinar will focus on the impact of new requirements, the impact of future requirements and what is being done to try and mitigate these impacts including the outcome of the end of February meeting between Michael Gove and Maroš Šefčovič on the Northern Ireland Protocol.
BIA Brexit Briefing webinars provide a monthly update on Government policy, progress of working groups, and how these potentially affect companies in life sciences. Visit our dedicated microsite www.biabrexit.org to view all the information and guidance for the sector.